Sign Up to like & get
recommendations!
1
Published in 2018 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-nb2018-105
Abstract: In two pancreatic cancer trials-the randomized phase III PRODIGE 24/CCTG PA.6 and PREOPANC-1 trials-researchers found that experimental drug regimens for patients with resectable adenocarcinomas increased overall survival or showed a trend in that direction. The…
read more here.
Keywords:
survival seen;
improved survival;
seen pancreatic;
pancreatic cancer ... See more keywords